Pnc Financial Services Group, Inc. Charles River Laboratories International, Inc. Transaction History

Pnc Financial Services Group, Inc.

  • $148 Billion
  • Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 14,278 shares of CRL stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,278
Previous 11,362 25.66%
Holding current value
$1.51 Million
Previous $2.24 Million 17.74%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025
BUY
$178.58 - $220.69 $520,739 - $643,532
2,916 Added 25.66%
14,278 $2.64 Million
Q3 2024

Nov 08, 2024
SELL
$187.96 - $245.29 $51,501 - $67,209
-274 Reduced 2.35%
11,362 $2.24 Million
Q2 2024

Aug 09, 2024
SELL
$206.39 - $268.73 $21,877 - $28,485
-106 Reduced 0.9%
11,636 $2.4 Million
Q1 2024

May 10, 2024
BUY
$203.52 - $273.43 $51,287 - $68,904
252 Added 2.19%
11,742 $3.18 Million
Q4 2023

Feb 09, 2024
BUY
$164.52 - $238.84 $99,699 - $144,737
606 Added 5.57%
11,490 $2.72 Million
Q3 2023

Nov 13, 2023
SELL
$194.44 - $217.61 $1,361 - $1,523
-7 Reduced 0.06%
10,884 $2.13 Million
Q2 2023

Aug 11, 2023
SELL
$183.71 - $210.25 $116,655 - $133,508
-635 Reduced 5.51%
10,891 $2.29 Million
Q1 2023

May 15, 2023
SELL
$191.89 - $259.92 $40,296 - $54,583
-210 Reduced 1.79%
11,526 $2.33 Million
Q4 2022

Feb 10, 2023
BUY
$197.11 - $250.07 $49,277 - $62,517
250 Added 2.18%
11,736 $2.56 Million
Q3 2022

Nov 10, 2022
BUY
$182.44 - $250.54 $20,615 - $28,311
113 Added 0.99%
11,486 $2.26 Million
Q2 2022

Aug 12, 2022
BUY
$204.13 - $302.4 $240,056 - $355,622
1,176 Added 11.53%
11,373 $2.43 Million
Q1 2022

May 12, 2022
BUY
$255.51 - $362.11 $31,172 - $44,177
122 Added 1.21%
10,197 $2.9 Million
Q4 2021

Feb 11, 2022
BUY
$351.38 - $448.68 $2.08 Million - $2.65 Million
5,914 Added 142.13%
10,075 $3.8 Million
Q3 2021

Nov 05, 2021
BUY
$372.64 - $458.3 $372 - $458
1 Added 0.02%
4,161 $1.72 Million
Q2 2021

Aug 06, 2021
SELL
$294.17 - $371.65 $461,258 - $582,747
-1,568 Reduced 27.37%
4,160 $1.54 Million
Q1 2021

May 07, 2021
SELL
$249.67 - $299.48 $294,111 - $352,787
-1,178 Reduced 17.06%
5,728 $1.66 Million
Q4 2020

Feb 12, 2021
BUY
$222.0 - $252.62 $52,170 - $59,365
235 Added 3.52%
6,906 $1.73 Million
Q3 2020

Nov 06, 2020
SELL
$175.56 - $226.45 $322,679 - $416,215
-1,838 Reduced 21.6%
6,671 $1.51 Million
Q2 2020

Aug 07, 2020
BUY
$118.84 - $189.72 $31,136 - $49,706
262 Added 3.18%
8,509 $1.48 Million
Q1 2020

May 08, 2020
BUY
$98.9 - $178.34 $178,118 - $321,190
1,801 Added 27.94%
8,247 $1.04 Million
Q4 2019

Feb 07, 2020
SELL
$126.05 - $152.76 $914,996 - $1.11 Million
-7,259 Reduced 52.97%
6,446 $984,000
Q3 2019

Nov 08, 2019
SELL
$125.07 - $143.67 $961,288 - $1.1 Million
-7,686 Reduced 35.93%
13,705 $1.81 Million
Q2 2019

Aug 09, 2019
SELL
$123.4 - $148.55 $252,229 - $303,636
-2,044 Reduced 8.72%
21,391 $0
Q1 2019

May 10, 2019
SELL
$104.82 - $146.73 $96,958 - $135,725
-925 Reduced 3.8%
23,435 $0
Q4 2018

Feb 08, 2019
SELL
$105.09 - $137.23 $45,924 - $59,969
-437 Reduced 1.76%
24,360 $2.76 Million
Q3 2018

Nov 09, 2018
BUY
$112.11 - $134.54 $236,776 - $284,148
2,112 Added 9.31%
24,797 $0
Q2 2018

Aug 10, 2018
SELL
$102.37 - $117.25 $215,898 - $247,280
-2,109 Reduced 8.51%
22,685 $0
Q1 2018

May 11, 2018
BUY
$98.19 - $115.2 $67,063 - $78,681
683 Added 2.83%
24,794 $0
Q4 2017

Feb 09, 2018
BUY
$100.43 - $118.09 $166,914 - $196,265
1,662 Added 7.4%
24,111 $0
Q3 2017

Nov 13, 2017
BUY
$96.72 - $109.26 $2.17 Million - $2.45 Million
22,449
22,449 $0

Others Institutions Holding CRL

# of Institutions
702
Shares Held
50.8M
Call Options Held
122K
Put Options Held
239K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $5.39B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email